JP2014511827A5 - - Google Patents

Download PDF

Info

Publication number
JP2014511827A5
JP2014511827A5 JP2013558271A JP2013558271A JP2014511827A5 JP 2014511827 A5 JP2014511827 A5 JP 2014511827A5 JP 2013558271 A JP2013558271 A JP 2013558271A JP 2013558271 A JP2013558271 A JP 2013558271A JP 2014511827 A5 JP2014511827 A5 JP 2014511827A5
Authority
JP
Japan
Prior art keywords
derived
pharmaceutical composition
adipose tissue
composition according
acne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013558271A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014511827A (ja
JP6038821B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2012/000274 external-priority patent/WO2012122604A1/en
Publication of JP2014511827A publication Critical patent/JP2014511827A/ja
Publication of JP2014511827A5 publication Critical patent/JP2014511827A5/ja
Application granted granted Critical
Publication of JP6038821B2 publication Critical patent/JP6038821B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013558271A 2011-03-15 2012-03-15 医薬組成物およびその局所使用 Expired - Fee Related JP6038821B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2011900932 2011-03-15
AU2011900932A AU2011900932A0 (en) 2011-03-15 Pharmaceutical compositions and topical use thereof
AU2012900140 2012-01-13
AU2012900140A AU2012900140A0 (en) 2012-01-13 Pharmaceutical compositions and topical use thereof
PCT/AU2012/000274 WO2012122604A1 (en) 2011-03-15 2012-03-15 Pharmaceutical compositions and topical use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016215032A Division JP2017031214A (ja) 2011-03-15 2016-11-02 医薬組成物およびその局所使用

Publications (3)

Publication Number Publication Date
JP2014511827A JP2014511827A (ja) 2014-05-19
JP2014511827A5 true JP2014511827A5 (enExample) 2015-08-13
JP6038821B2 JP6038821B2 (ja) 2016-12-07

Family

ID=46829963

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013558271A Expired - Fee Related JP6038821B2 (ja) 2011-03-15 2012-03-15 医薬組成物およびその局所使用
JP2016215032A Pending JP2017031214A (ja) 2011-03-15 2016-11-02 医薬組成物およびその局所使用
JP2018013476A Expired - Fee Related JP6621853B2 (ja) 2011-03-15 2018-01-30 医薬組成物およびその局所使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016215032A Pending JP2017031214A (ja) 2011-03-15 2016-11-02 医薬組成物およびその局所使用
JP2018013476A Expired - Fee Related JP6621853B2 (ja) 2011-03-15 2018-01-30 医薬組成物およびその局所使用

Country Status (8)

Country Link
US (2) US9730964B2 (enExample)
EP (2) EP2685993B9 (enExample)
JP (3) JP6038821B2 (enExample)
CN (2) CN106581067B (enExample)
AU (1) AU2012229890B2 (enExample)
CA (1) CA2865652C (enExample)
DK (1) DK3156060T3 (enExample)
WO (1) WO2012122604A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201606745XA (en) * 2011-09-23 2016-10-28 Cell Ideas Pty Ltd Therapeutics using adipose cells and cell secretions
JP2023002772A (ja) * 2011-09-23 2023-01-10 レジニアス リミテッド 脂肪細胞および細胞分泌物を使用する治療
WO2015038951A1 (en) * 2013-09-12 2015-03-19 Ohio State Innovation Foundation Topical compounds containing adipose-derived hormones for the rejuvenation of skin
JP5991687B2 (ja) * 2014-07-23 2016-09-14 学校法人日本大学 脱分化脂肪細胞の製造方法
IT201700102994A1 (it) * 2017-09-14 2019-03-14 Genlife Sagl Catalizzatore rigenerativo di tessuti e relativo procedimento di realizzazione
MX2019014426A (es) 2017-10-02 2020-02-05 Fukuoka Hirotaro Composicion farmaceutica para usarse en la mejora de la calidad del cuero cabelludo y la piel, de la cicatrizacion de heridas o mejora de la calidad del cabello.
KR102646145B1 (ko) * 2018-05-31 2024-03-11 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물
WO2024151321A2 (en) * 2022-08-05 2024-07-18 Trustees Of Tufts College Systems and methods for commercial scale cultured adipose tissue production
WO2024145258A1 (en) 2022-12-27 2024-07-04 AVITA Medical Americas, LLC System for automated preparation of a regenerative epidermal suspension and related methods of use

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296099A (en) 1976-11-30 1981-10-20 L'oreal Process for extracting embryonic calf skin and pharmaceutical compositions containing the same
US5762947A (en) * 1997-05-09 1998-06-09 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic skin conditioning compositions containing a salicyloxy α-carboxy acid
CN1352696A (zh) * 1999-03-10 2002-06-05 匹兹堡大学联邦制高等教育 脂肪来源的干细胞和网格
IT1309453B1 (it) * 1999-10-01 2002-01-23 Consorzio Per Gli Studi Uni Substrato bioartificiale per la realizzazione di tessuti e organianimali, in particolare umani.
CA2472180A1 (en) 2001-12-31 2003-07-17 Isolagen Technologies, Inc. Hair follicle growth
WO2005013885A2 (en) * 2003-08-07 2005-02-17 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
EP2450433A3 (en) 2003-10-08 2012-08-08 Vet-Stem Inc Methods of preparing and using stem cell compositions and kits comprising the same
WO2007026356A2 (en) 2005-08-29 2007-03-08 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
FR2894961B1 (fr) * 2005-12-16 2008-05-16 Oreal Utilisation de ceramides pour depigmenter la peau
CN101400787B (zh) * 2006-01-27 2013-01-23 株式会社Prostemics 采用脂肪来源成体干细胞大量制造生长因子的方法
JP5240715B2 (ja) * 2006-08-08 2013-07-17 国立大学法人名古屋大学 脂肪組織由来多分化能幹細胞を含有する細胞製剤
US8835170B2 (en) * 2006-10-06 2014-09-16 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
KR101220239B1 (ko) 2008-04-01 2013-01-09 바이오스펙트럼 주식회사 식물성 펩톤을 포함하는 줄기세포 증식 촉진용 조성물
KR100994133B1 (ko) 2008-04-15 2010-11-15 송신혜 문양이 삽입된 유리 제품 및 이의 제조 방법
FR2938334A1 (fr) 2008-11-13 2010-05-14 Galderma Res & Dev Modulateurs de l'adfp dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
JP5633859B2 (ja) * 2009-10-08 2014-12-03 国立大学法人名古屋大学 脂肪組織由来間葉系幹細胞を含有する免疫抑制剤及びその用途
AU2009251017A1 (en) 2009-12-17 2011-07-07 Regeneus Ltd. Therapeutic methods
KR100995133B1 (ko) 2010-02-10 2010-11-18 허쉬바이오주식회사 지방조직 유래 줄기세포 및 단핵구로부터 세포성장인자의 생산방법 및 그 이용
KR101749218B1 (ko) 2010-04-26 2017-06-20 (주)프로스테믹스 양모 효과를 가지는 인간 지방유래 줄기세포의 조건 배지 및 이의 용도
WO2012047733A2 (en) * 2010-09-29 2012-04-12 Aidan Research And Consulting, Llc. Treatment of acne by conditioned media

Similar Documents

Publication Publication Date Title
JP2014511827A5 (enExample)
CL2014001162A1 (es) Inoculantes microbianos que comprenden lactobacillus; composicion fertilizante que comprenden los mismos; metodo para aumentar crecimiento y/o la productividad de plantas.
EP2920293A4 (en) MICROBIAL STRAINS, COMPOSITIONS AND METHODS FOR EXPANDING THE PHOSPHATE AVAILABLE FOR PLANTS
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
CA2840307C (en) Progenitor cells of mesodermal lineage
WO2012056457A3 (en) Compositions and methods for activating expression by a specific endogenous mirna
PL2444081T3 (pl) Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol
EP2916860A4 (en) COMPOSITION FOR THE TREATMENT OF DIABETES OR OBESITAS-CONDITIONING DIABETES WITH AN OXYNTOMODULIN ANALOG
EP2558478A4 (en) AT 5 POSITIONS MODIFIED PYRIMIDINES AND THEIR USE
MA41031A (fr) Conjugués cystéamine-acide gras et leur utilisation comme activateurs de l'autophagie
CL2012003723A1 (es) Compuestos derivados de acido 2-quinolinil-acetico; composicion farmaceutica; y uso en el tratamiento del vih y sida.
GB2562396A (en) Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof
MX344521B (es) Aminas heterociclicas y sus usos.
EP2830646A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLISM DISEASES
EP2658969A4 (en) FROM ULTRASOUND CAVITATION GENERATING ELECTROGENOUS OR MESENCHYMAL VASCULAR EXTRACTS, FAT-WEAVED CELLS THEREOF, AND THEIR USE
IN2015DN00934A (enExample)
EP2710117A4 (en) RECOMBINANT MICROORGANISMS AND METHOD OF USE THEREOF
IL232515A0 (en) nadph 4 oxidase inhibitors and pharmaceutical preparations containing them
CL2013001314A1 (es) Composicion de yogur de consistencia espesa que comprende microorganismos probióticos no replicantes.
EP2685993B8 (en) Composition adipose tissue-derived secretions for use in the topical treatment or prevention of acne
EP2854826A4 (en) SELECTION AND USE OF MILK ACID BACTERIA FOR PREVENTING BONE REMOVAL IN MAMMALS
PH12014501240A1 (en) Film containing compositions
FR2981072B1 (fr) Compose sensible au ph, utilisation, composition et procede de traitement le mettant en œuvre
CL2013000788A1 (es) Compuestos derivados de 1,2,4-oxadiazol, inhibidores de la proteina activadora de 5-lipoxigenasa (flap); composicion farmaceutica; metodo de tratamiento; y uso para el tratamiento de un trastorno mediado por leucotrienos tal como enfermedades cardiovasculares, inflamatorias, alergicas, pulmonares y fibroticas, renales y cancer.
EP2635281A4 (en) METHOD AND COMPOSITIONS FOR PREVENTING AND TREATING HEART HYPERTROPHY